scholarly journals Population Pharmacokinetics and Dosing Optimization of Gentamicin in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy

2022 ◽  
Vol Volume 16 ◽  
pp. 13-22
Author(s):  
Sha He ◽  
Zeneng Cheng ◽  
Feifan Xie
2008 ◽  
Vol 47 (3) ◽  
pp. 173-180 ◽  
Author(s):  
Arantxazu Isla ◽  
Alicia Rodríguez-Gascón ◽  
Iñaki F Trocóniz ◽  
Lorea Bueno ◽  
María Ángeles Solinís ◽  
...  

2021 ◽  
Vol 9 (3) ◽  
Author(s):  
Jongsung Hahn ◽  
Kyoung Lok Min ◽  
Soyoung Kang ◽  
Seungwon Yang ◽  
Min Soo Park ◽  
...  

To the best of our knowledge, this is the first large prospective pharmacokinetic/pharmacodynamic (PK/PD) study of piperacillin-tazobactam in ECMO patients. We used piperacillin-tazobactam plasma concentration data from four different cases (concomitant use of ECMO and CVVHDF, receiving ECMO only, weaned from ECMO and receiving CVVHDF, and weaned from ECMO and not receiving CVVHDF) to provide preliminary insights into the incremental effects of critical illness, ECMO, and CVVHDF on PK.


Sign in / Sign up

Export Citation Format

Share Document